66 related articles for article (PubMed ID: 17624425)
1. The first ankyrin-like repeat is the minimum indispensable key structure for functional assembly of homo- and heteromeric TRPC4/TRPC5 channels.
Schindl R; Frischauf I; Kahr H; Fritsch R; Krenn M; Derndl A; Vales E; Muik M; Derler I; Groschner K; Romanin C
Cell Calcium; 2008 Mar; 43(3):260-9. PubMed ID: 17624425
[TBL] [Abstract][Full Text] [Related]
2. Pore residues of transient receptor potential channels canonical 1 and 4 heteromer determine channel properties.
Park CH; Kim J; Lee JE; Kwak M; So I
Am J Physiol Cell Physiol; 2023 Jul; 325(1):C42-C51. PubMed ID: 37212545
[TBL] [Abstract][Full Text] [Related]
3. Functional characteristics of TRPC4 channels expressed in HEK 293 cells.
Sung TS; Kim MJ; Hong S; Jeon JP; Kim BJ; Jeon JH; Kim SJ; So I
Mol Cells; 2009 Feb; 27(2):167-73. PubMed ID: 19277498
[TBL] [Abstract][Full Text] [Related]
4. (-)-Englerin A is a potent and selective activator of TRPC4 and TRPC5 calcium channels.
Akbulut Y; Gaunt HJ; Muraki K; Ludlow MJ; Amer MS; Bruns A; Vasudev NS; Radtke L; Willot M; Hahn S; Seitz T; Ziegler S; Christmann M; Beech DJ; Waldmann H
Angew Chem Int Ed Engl; 2015 Mar; 54(12):3787-91. PubMed ID: 25707820
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Characterization of a Specific Iodine-125-Labeled TRPC5 Radioligand.
Yu Y; Liang Q; Du L; Jiang H; Gu J; Hu H; Tu Z
ChemMedChem; 2020 Oct; 15(19):1854-1860. PubMed ID: 32717096
[TBL] [Abstract][Full Text] [Related]
6. Human TRPC5 structures reveal interaction of a xanthine-based TRPC1/4/5 inhibitor with a conserved lipid binding site.
Wright DJ; Simmons KJ; Johnson RM; Beech DJ; Muench SP; Bon RS
Commun Biol; 2020 Nov; 3(1):704. PubMed ID: 33230284
[TBL] [Abstract][Full Text] [Related]
7. A greasy business: Identification of a diacylglycerol binding site in human TRPC5 channels by cryo-EM.
Storch U; Mederos Y Schnitzler M; Gudermann T
Cell Calcium; 2021 Apr; 97():102414. PubMed ID: 33930818
[TBL] [Abstract][Full Text] [Related]
8. An ex vivo perfused ventilated murine lung model suggests lack of acute pulmonary toxicity of the potential novel anticancer agent (-)-englerin A.
Schremmer C; Steinritz D; Gudermann T; Beech DJ; Dietrich A
Arch Toxicol; 2022 Apr; 96(4):1055-1063. PubMed ID: 35165752
[TBL] [Abstract][Full Text] [Related]
9. Discovery of pyridazinone derivatives bearing tetrahydroimidazo[1,2-a]pyrazine scaffold as potent inhibitors of transient receptor potential canonical 5 to ameliorate hypertension-induced renal injury in rats.
Xu Y; Ren Y; Zhang J; Niu B; Liu M; Xu T; Zhang X; Shen J; Wang K; Cao Z
Eur J Med Chem; 2024 Jun; 275():116565. PubMed ID: 38878518
[TBL] [Abstract][Full Text] [Related]
10. The plastic landscape of repeat proteins.
Ferreiro DU; Komives EA
Proc Natl Acad Sci U S A; 2007 May; 104(19):7735-6. PubMed ID: 17483477
[No Abstract] [Full Text] [Related]
11. Biological Effects of Modifications of the Englerin A Glycolate.
Seenadera SPD; Long SA; Akee R; Bermudez G; Parsonage G; Strope J; Peer C; Figg WD; Parker KA; Beech DJ; Beutler JA
ACS Med Chem Lett; 2022 Sep; 13(9):1472-1476. PubMed ID: 36105325
[TBL] [Abstract][Full Text] [Related]
12. Novel Targets for Stroke Therapy: Special Focus on TRPC Channels and TRPC6.
Liu L; Gu L; Chen M; Zheng Y; Xiong X; Zhu S
Front Aging Neurosci; 2020; 12():70. PubMed ID: 32256338
[TBL] [Abstract][Full Text] [Related]
13. Structure-Function Relationship and Physiological Roles of Transient Receptor Potential Canonical (TRPC) 4 and 5 Channels.
Kim J; Ko J; Hong C; So I
Cells; 2019 Dec; 9(1):. PubMed ID: 31892199
[TBL] [Abstract][Full Text] [Related]
14. Trpc6 inactivation confers protection in a model of severe nephrosis in rats.
Kim EY; Yazdizadeh Shotorbani P; Dryer SE
J Mol Med (Berl); 2018 Jul; 96(7):631-644. PubMed ID: 29785489
[TBL] [Abstract][Full Text] [Related]
15. Electron cryo-microscopy structure of the canonical TRPC4 ion channel.
Vinayagam D; Mager T; Apelbaum A; Bothe A; Merino F; Hofnagel O; Gatsogiannis C; Raunser S
Elife; 2018 May; 7():. PubMed ID: 29717981
[TBL] [Abstract][Full Text] [Related]
16. Proline-dependent and basophilic kinases phosphorylate human TRPC6 at serine 14 to control channel activity through increased membrane expression.
Hagmann H; Mangold N; Rinschen MM; Koenig T; Kunzelmann K; Schermer B; Benzing T; Brinkkoetter PT
FASEB J; 2018 Jan; 32(1):208-219. PubMed ID: 28877958
[TBL] [Abstract][Full Text] [Related]
17. Identification of a membrane-targeting domain of the transient receptor potential canonical (TRPC)4 channel unrelated to its formation of a tetrameric structure.
Myeong J; Kwak M; Hong C; Jeon JH; So I
J Biol Chem; 2014 Dec; 289(50):34990-5002. PubMed ID: 25349210
[TBL] [Abstract][Full Text] [Related]
18. Canonical transient receptor potential (TRPC) 1 acts as a negative regulator for vanilloid TRPV6-mediated Ca2+ influx.
Schindl R; Fritsch R; Jardin I; Frischauf I; Kahr H; Muik M; Riedl MC; Groschner K; Romanin C
J Biol Chem; 2012 Oct; 287(42):35612-35620. PubMed ID: 22932896
[TBL] [Abstract][Full Text] [Related]
19. Update on vascular endothelial Ca(2+) signalling: A tale of ion channels, pumps and transporters.
Moccia F; Berra-Romani R; Tanzi F
World J Biol Chem; 2012 Jul; 3(7):127-58. PubMed ID: 22905291
[TBL] [Abstract][Full Text] [Related]
20. Novel pyrazole compounds for pharmacological discrimination between receptor-operated and store-operated Ca(2+) entry pathways.
Schleifer H; Doleschal B; Lichtenegger M; Oppenrieder R; Derler I; Frischauf I; Glasnov TN; Kappe CO; Romanin C; Groschner K
Br J Pharmacol; 2012 Dec; 167(8):1712-22. PubMed ID: 22862290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
